Your browser doesn't support javascript.
loading
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies.
Patel, Manish R; Donnellan, William; Byrne, Michael; Asch, Adam S; Zeidan, Amer M; Baer, Maria R; Fathi, Amir T; Kuykendall, Andrew T; Zheng, Fred; Walker, Chris; Cheng, Lulu; Marando, Cindy; Savona, Michael R.
Afiliação
  • Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL. Electronic address: mpatel@flcancer.com.
  • Donnellan W; Tennessee Oncology, PLLC, Chattanooga, TN.
  • Byrne M; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Asch AS; Stephenson Cancer Center, Oklahoma University, Oklahoma City, OK.
  • Zeidan AM; Yale University and Yale Cancer Center, New Haven, CT.
  • Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Fathi AT; Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Kuykendall AT; Moffitt Cancer Center, FL.
  • Zheng F; Incyte Corporation, Wilmington, DE.
  • Walker C; Incyte Corporation, Wilmington, DE.
  • Cheng L; Incyte Corporation, Wilmington, DE.
  • Marando C; Incyte Corporation, Wilmington, DE.
  • Savona MR; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
Clin Lymphoma Myeloma Leuk ; 23(9): 674-686, 2023 09.
Article em En | MEDLINE | ID: mdl-37290996

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas / Mielofibrose Primária / Antineoplásicos Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas / Mielofibrose Primária / Antineoplásicos Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2023 Tipo de documento: Article